3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase EARLY_PHASE1
1
Phase 3
1
Phase 2/3
1
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Breast
1
Conditions
Neoplasms
3
Colonic Neoplasms
3
Breast Neoplasms
3
Pain
2
Leiomyoma
2
Wounds and Injuries
1
Stomatitis
1
Postoperative Hemorrhage
1
Mucositis
1
Malignant Pleural Neoplasm
1
Inflammatory Bowel Diseases
1
Ileus
1
Head and Neck Neoplasms
1
Feeding and Eating Disorders
1
Diverticulitis
1
Colorectal Neoplasms
1
Cancer Pain
1
Agnosia
1
Interventions
Morphine
2
resiniferatoxin
1
incobotulinumtoxinA
1
fulranumab
1
cannabichromene
1
alvimopan
1
Tablets
1
Surveys and Questionnaires
1
Standard of Care
1
Pain Management
1
Oxycodone
1
Occupational Therapy
1
Massage
1
Lidocaine
1
Lenalidomide
1
Ketamine
1
Gels
1
Fentanyl
1
Dronabinol
1
Cannabidiol
1
Animal Assisted Therapy
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Cancer Pain
×
Lidocaine
×
Clear all
NCT05800834
2023-09-28
MorphineGEL
Instituto Nacional de Cancer, Brazil
Phase 2
Unknown
106 enrolled